N
'K cells are cytotoxic lymphocytes that are capable of lysing a variety of target cells, including tumor cells, virus-infected cells, and cells infected with intracellular bacteria. NK cell-mediated killing does not require previous sensitisation and is MHC unrestricted (1) , and as such, forms a first line of defense against microbial pathogens or tumor growth. In the case of primary viral refection, NK cell responses are reduced early and are temporally distinct from those of T lymphocytes. The early response to viral infection is associated with increases in both systemic and local type I IFN (IFN-ot/[3) production, peaking at 3-5 d after infection, and closely mirroring the time course of NK cell activation, blastogenesis, and the augmented cytolytic activity that is seen m viral infection (2) .
IFN regulatory factor-1 (IRF-1), an IFN-inducible transcripnonal activator, binds regions within the promoters of type I IFNs and several IFN-inducible genes, and has been implicated as a mediator of the IFN-induced antiviral state (3, 4) . IP,.F-1 is constitutively expressed in many cell types, and its expression can be strongly enhanced by type I and II IFNs, viral infection, double-stranded ILNA, and cytokines such as IL-6 (4, 5) . The functional deletion of IRF-1 does not, however, fully ablate the expression of IFN and IFNinducible genes. We have previously demonstrated in vitro induction of type I IFN genes by polyinosinic:polycytidylic acid (pI:pC) and Newcastle disease virus to be I1LF-1 dependent and independent, respectively (6) . In addition, IRF-l-dependent antiviral effects of IFNs and the course of viral infection in IB.F-l-deficient mice have been shown to be dependent on the type of virus investigated (7), suggesting IRF-l~dependent and -independent pathways in the induction of antiviral states.
To clarify the role of I1LF-1 m NK cell function, we have examined the cytolytic activity of NK cells from IRF-1-deficient mice in response to lymphocytic choriomeningitis virus (LCMV) and pI:pC in vivo, and to IFN-13, IL-2, and IL-12 in vitro. Killing of NK-sensitive targets in vitro by spleen NK cells from IP, F-l-deficient mice was found to be markedly reduced both after in vivo and in vitro activation of NK cells. A defect was also evident in the clearance of parental donor cells from the circulation of I1LF-1-deficient hosts and in the elimination of a syngeneic MHC class I-deficient tumor in vivo, both processes known to be mediated by NK cells. Our results clearly indicate that IlkF-1 plays a crucial role in the induction of NK cellmediated cytotoxic and effector functions in vivo.
Materials and Methods
Mice. C57BL/6 mice deficient in IRF-1 (6) were genotyped by genomic Southern blotting of tail DNA as described previ-ously (6) . For experiments involving the injection of FI cells, C57BL/6 (H-2 b) IRF-1 +/-mice were bred with A/J (H-2 k) IRF-1 -/-mice (kindly provided by Dr. J. Penninger, Amgen Institute, Toronto). Mice were housed m specific pathogen-free conchtions, and littermate controls were used within experiments. 
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Persistence of Parental Donor Cells. Spleen and LN MNC cells
were prepared from 6--8-wk-old C57BL/6 (H-2 b) and C57BL/6 X A/J F 1 (H-2 b/k) mice by density gradient centrifugation. After two washes in CM, the cells were labeled with FITC (Sigma Immunochemicals, St. Louis, MO; 30 p~g/ml in PBS) for 18 rain at 37°C/5% CO2. Excess FITC was removed by centrifugation through 6% BSA in PBS, and 2 X 107 cells in 0.2 ml PBS were injected into the lateral tail vein of rectpient mice (C57BL/6 X A/J F1, IRF-1 +/-, or IRF-1-/-). The fate of the donor cells was monitored by flow cytometry of peripheral blood and LN cells. NK activity was induced in recipient mice by injection of 0.1 mg i.p. pI:pC at 1 and 24 h after injecuon of donor cells.
Flow Cytometric Analysis. MNC were preincubated with antiFc~/R mAb (Fc block; Pharn'nngen, San Diego, CA) for 10 rain at room temperature and were subsequently incubated on ice with mAbs [anta-NKl.1 (PK136, PE conjugated), antl-CD3 (145-2Cll, FITC-conjugated), anti-CD69 (H1.2F3, biotinylated), anti-CD25 (7D4, baotinylated), and anti-CDlla (M17/4, biotmlyated); all mAbs were from PharMingen (San Diego, CA)] for 30 rain in 0.1 ml of PBS containing 1% BSA and 0.1% sodram azide. Cells were washed with PBS and analyzed by flow cytometry (FACScalibur ®, Becton Dacklnson & Co., San Jose, CA) using CellQuest software (Becton Dickinson). Viable lymphocytes were gated on the basis of forward and side scatter characteristlcs, and 10,000 gated events were analyzed.
Results
NK Cytotoxidty in IRF-I-deficient Mice in Response to LCMVInfection andpI:pC Treatment.
The role of IRF-1 in the induction of NK cell cytotoxicity in response to LCMV infection was investigated. 72 h after high dose infection with 2 X 106 PFU LCMV, significant lysis of the prototypic NK-sensitive cell line YAC-1 was observed with spleen cells from 1RF-1 +/+ mice, but not with cells from IRF-1 -/-mice ( Fig. 1 A) . Spleen cells from uninfected IRF-I+/+ or IRF-1 -/-mice displayed no measurable lyric activity (data not shown). Stimulation ofNK lytic activity in response to the type I IFN inducer pI:pC was also investigated. 24 h after administration of 0.1 mg i.v. pI: pC, significant lysis of YAC-1 target cells was clearly observed in wild-type mice (Fig. 1 B) . However, pI:pCtreated IRF-1 -/-mice exhibited markedly reduced lytic activity compared to wild-type mice, confirming the results obtained with LCMV.
IFN-~8-enhanced Cytolytic Activity In Vitro.
To address the possibility that a defect in type I IFN production in IRF-1-/-mice was responsible for the lack of cytotoxicity observed in IRF-1 -/-mice, spleen NK cells were incubated in vitro with IFN-[3. IFN-[3 induced a dose-dependent activation of NK-mediated lyric activity in Wild-type animals, with a maximal effect obtained in the presence of 1,000 IU/ml IFN-[3 ( Fig. 2) , as reported previously (9) . IRF-l-deficient splenocytes demonstrated maximal lytic activity at the same dose of IFN-13, but exhibited greatly reduced lyric activity compared to wild-type controls.
IL-12-enhanced Cytolytic Activity In Vitro.
Spleen MNCderived from IRF-I+/-and IRF-1-/-mice were incubated in the presence of 10 ng/ml IL-12. Significant lysis of the target cell line by IRF-1 +/-spleen NK cells was induced by IL-12 ( Fig. 3 A) , while IL-12 failed to augment the cytolytic activity oflRF-l-deficient NK cells. Analysis of the supernatants from spleen cells cultured in the presence of 10 ng/ml IL-12 revealed a defect in IFN-~/production in IRF-1-/--derived spleen cells (Fig. 3 B) .
IL-2-stimulated Proliferation and Cytolytic Activity In Vitro.
Incubation in the presence of 500 U/ml IL-2 NK activity was induced in recipient mice by the injection ofpI:pC at the time of donor cell injection and at 24 h after injection. Persistence of FITC-labeled donor cells in the LN of recipient animals was followed by flow cytometry (Fig. 6 ). While F 1 syngeneic donor cells persisted in F1 hosts, C57BL/6-derived parental donor ceils (H-2 b) were eliminated in F1 IP,-F-1 +/-mice. In contrast, F1 I1LF-1 -/-mice were unable to eliminate the parental donor cell graft.
Normal Numbers and Surface Markers of lRF-1 -/-NK1.1 + NK Cells.
The potential role of IRF-1 in the ontogeny and activation of murine NK cells was addressed by flow cytometric analysis of spleen MNC that were obtained from pI:pC-treated mice (Fig. 7) . No significant difference in the number of NKI.I+/CD3 -cells was evident between heterozygous and homozygous IP, F-1--deficient mice, and the number of CD3-/NKI.1 + cells expressing the early activation marker CD69 was similar in both groups of mine. Comparable numbers of CD3-/NKI.1 + cells also expressed the oL chain of the IL-2 receptor (CD25) and CDlla, the ot chain of LFA-1, in both heterozygous and homozygous IP, F-l-deficient mice (data not shown).
Discussion
From the data presented in this study, it is clear that IP, F-1 plays an essential role in the augmented lytic activity of murine NK cells after viral infection, stimulation with type I IFNs, or stimulation with IL-12. Flow cytometric analysis of spleen MNC from heterozygous and homozygous IRF-l-deficient mice indicates that IILF-1 does not play a role in the ontogeny of NK cells, and that the defect seen in NK cell-mediated cytotoxicity is not caused by a lack of NK celR: In addition, the expression of the surface molecules CD25,'CD69, and LFA-1 by NK cells was similar in ItkF-l-deficient mice compared to heterozygous control mice. One explanation for our findings is that an inherent defect in the prodfiction of type I IFNs exists in IRF-1 -/-mice, leading to the insufficient activation of NK cells. The absolute role of IP, F-1 in the induction of type I IFNs is controversial, and the effect of lRF-1 deficiency on type I IFN production remains unclear. IP,.F-1 has been shown to bind regions within the promoter of type I IFNs (3, 4) , and overexpresslon of IRF-1 results in IFN-~ production in some cell lines (4, 12) . However, although the induction of type I IFN mRNAs by pI:pC has been shown to be dramatically reduced in vitro in IRF-l-deficient embryonic fibroblasts compared to wild-type controls (6) between wild-type and IRF-l-deficient mice (13) . In our study, the addition of exogenous IFN-~ to spleen ceils in vitro clearly does not fully restore the lytic activity of IRF-1 /-NK ceils to that seen in wild-type ceils. This implies that the diminished NK activity seen upon in vxvo induction may not be caused by a defect in type I IFN production, and that other factors intrinsic to NK ceils and essential for lytic activity are disrupted in IRF-1-/-mice. IL-12 was first identified as an inducer of NK ceil-mediated cytotoxicity (14) , presumably through the induction of genes involved in target cell lysis, such as perforin or granzyme B (15) . Another important function of IL-12 is the reduction of IFN-~/production in resting and activated NK cells (16) , a key step in the innate response to acute infection. In this study, we report that IRF-l-deficient NK cells are incapable of responding appropriately to IL-12 stimulation in vitro, since both enhanced lyric activity and IFN-y production are defective in splenocytes derived from IkF-1 -/-mice. Our data suggest that IL-12-mediated signaling itself is defective in the NK ceils of IR.F-l-deficient mice, correlating with a recent report that IL-12-deficlent mice exhibit a defect in both NK cell cytolytic activity and IFN-y production (17) . IL-12 has also been implicated as a central mediator of acute GVHD in BDF 1 mice injected with B6 donor splenocytes. Neutralization of endogenous IL-12 moderated acute GVHD and resulted in decreased splenic NK activity and IFN-y production (18) . We therefore postulate that the defective rejection ofsemlailogenelc, hematopoetic donor cells by IRF-1 -/ mice is, at least in part, the result of aberrant IL-12-mediated signaling.
The functional response of NK cells to IL-2 stimulation in vitro was also found to be disrupted in IP,.F-1 knockout mice. Both proliferation and augmentation of lytic activity of IL-2-stimulated NK cells were defective, although the partial reduction in lytic activity seen in IRF-1 -/-compared to IR.F-1 +/-controls was not as profound as that seen after activation with type I IFNs or IL-12. It appears, therefore, that IL-2-mediated effects on NK cell function are not fully dependent on IP, F-1. The expression of some genes is critically dependent on IILF-1, for example, reducible nitric oxide synthase (iNOS) or guanylate-binding protein (19) . It has recently been suggested that NO may play a role in human NK cell-mediated cytotoxicity (20), and given the dependence of iNOS on IR.F-1 for induction, the possibility that the defect in NK cell-mediated cytotoxicity in I1LF-1 -/ mice is caused by the reduced production of NO was addressed in our laboratory. The nonspecific NO synthase inhibitor N-monomethyl-L-arginine and the iNOS-specific inhibitor aminoguanidine exhibited no inhibitory effect (at doses ranging from 10 nM to 1 raM) on pI:pC-induced, NK-mediated killing of YAC-1 target cells in vitro (data not shown). This suggests that NO does not play a role in NK cellmediated cytotoxicity, and supports the finding that perforin is predominately responsible for NK cell-mediated cytotoxicity (21, 22).
The expression of many IFN-inducible genes is mediated through IR.F-l-independent pathways, including doublestranded RNA-dependent protein kinase and 2'-5' oligoadenylate synthetase (6) . It is possible that the residual NK-mediated lytic activity of IRF-1 -/-cells observed in our experiments may be mediated via other transcription factors. Candidates include IFN-~/-inducible y-activated factor, via its association with the IFN-',/activation site, or IFN-stimulated gene factor 3 (ISGF3), which shares over- The data obtained an our in vivo studies of hybrid resistance to a hematopoietic graft, as well as the rejection of an MHC class I-negative tumor cell from a peripheral site of injection, confirm the in vitro data showing a lack of NK cell-mediated cytotoxicity in IRF-1-/-mice. While type I IFNs were induced in the in vitro models of NK activity by biological response modifiers, the rejection ofallogeneic grafts and MHC class I-negative tumor cells are models for which the role of endogenous IFNs remains to be elucidated. Our data does, at least indirectly, support findings that IL-12 plays a prominent role in the acute rejection of hematopoetlc allografts and MHC class Iynegative cells in the mouse.
In conclusion, the absence of the transcription factor IRF-1 leads to a defect in NK cell cytolytic activity induced in response to LCMV infection, pI:pC, IFN-[3, IL-12, or IL-2, which is not the result of reduced NK cell number, or of NK cell activation as assessed by the expression of the activation markers CD69 and CD25. In addition, MHC class I-deficient tumor cells are not eliminated, and clearance of parental donor cells is impaired in IRF-l-deficient mice. IRF-1 is therefore an essential mediator of normal NK cell function in the mouse.
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